BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, February 12, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 12, 2019
View Archived Issues
Targeting lymph node stage may nip metastases in the bud
Read More
Genome editing used to create models of GM1-gangliosidosis and Morquio syndrome type B
Read More
Free radicals can benefit the brain
Read More
Urethral macrophages are HIV reservoir
Read More
Xiamen University describes triggering receptor expressed on myeloid cells 2 polypeptides
Read More
Rho-associated protein kinase 1/2 inhibitors disclosed by Kadmon
Read More
Curigin patents nucleic acid molecules inhibiting MTOR and AR gene expression
Read More
Beijing Sanyou Liheze Biological Technology describes anticoagulant fusion protein
Read More
HDAC3 is a novel therapeutic target for ischemic stroke
Read More
Results presented from phase I/II CHAMPIONS study of SB-913
Read More
New biomarkers discovered tied to intracranial aneurysm
Read More
ADAR1-editing of cell-cycle-regulatory miRNAs is involved in progenitor malignant transformation
Read More
Tumor-specific near-infrared agent targeting PSMA for fluorescence-guided surgery in prostate cancer
Read More
Sterol regulatory element binding protein as a potential target for broad-spectrum antiviral agents
Read More
Viral-mediated TMBIM6 gene delivery protects against neonatal hypoxic ischemia
Read More
European Commission extends marketing authorization for Adcetris
Read More
Sprycel receives European approval in pediatric patients with newly diagnosed Ph+ ALL
Read More
Patient enrollment ongoing in phase I study of SER-401 in combination with nivolumab
Read More
FDA approves IND for ABBV-0805 for Parkinson's disease
Read More
Ascendis announces phase II trial of TransCon PTH to treat hypoparathyroidism
Read More
Increased miR-9 levels in CSF found to be a poor prognostic factor after subarachnoid hemorrhage
Read More
Bicycle awarded contract to identify novel inhibitors of PBPs of key bacterial pathogens
Read More
3SBio and Verseau collaborate in immuno-oncology
Read More
STELLAR-4 trial of selonsertib in compensated cirrhosis due to NASH does not meet week 48 endpoint
Read More
Redx's preclinical ROCK-II compound suppresses collagen deposition and pathways linked to fibrosis
Read More
Aduro doses first patient with ADU-S100 and Yervoy for melanoma in phase I trial
Read More
New phase III trial in China studies HC-1119 for metastatic CRPC
Read More
